Rockefeller Capital Management L.P. - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 47 filers reported holding SIGILON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$09500.0%0.00%
Q3 2022$0
-100.0%
950
-67.8%
0.00%
Q2 2022$2,000
-50.0%
2,9500.0%0.00%
Q1 2022$4,000
-50.0%
2,9500.0%0.00%
Q4 2021$8,000
-27.3%
2,950
+47.5%
0.00%
Q3 2021$11,0002,0000.00%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 10,370,369$58,592,0000.61%
HARBOURVEST PARTNERS LLC 740,740$4,185,0000.39%
Monashee Investment Management LLC 317,460$1,794,0000.33%
SOUNDMARK WEALTH MANAGEMENT, LLC 50,555$286,0000.10%
Artal Group S.A. 276,000$1,559,0000.04%
Choate Investment Advisors 66,666$377,0000.02%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$8,391,0000.01%
STATE OF WISCONSIN INVESTMENT BOARD 509,629$2,879,0000.01%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 229,500$1,297,0000.00%
Woodline Partners LP 34,200$193,0000.00%
View complete list of SIGILON THERAPEUTICS INC shareholders